The lymphatic vascular system in lymphangiogenesis invasion and metastasis a mathematical approach

Modeling and Simulation in Science, Engineering and Technology

Volumn , Issue 9780817647124, 2008, Pages

  Pepper, Michael S ^a   Lolas, Georgios ^b  

^a UNIVERSITY OF PRETORIA   (South Africa)

^b UNIVERSITY OF WEST ATTICA   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84872437972     PISSN: 21643679     EISSN: 21643725     Source Type: Book Series    
DOI: 10.1007/978-0-8176-4713-1_10     Document Type: Chapter

References (74)

1. Alberts, B., Bray, D., Lewis, J., Raff, M., Roberts, K., and Watson, J.D.: Molecular Biology of the Cell, Garland Publishing, New York (1994).
2. Alitalo, K., and Carmeliet, P.: Molecular mechanisms of lymphangiogenesis in health and disease, Cancer Cell, 1, 219–227 (2002).
3. Anderson, A.R.A., and Chaplain, M.A.J.: Continuous and discrete mathematical models of tumor induced angiogenesis, Bulletin of Mathematical Biology, 60, 857–899 (1998).
4. Andreasen, P.A., Kjøller, L., Christensen, L. and Duffy, M.J.: The urokinase-type plasminogen activator system in cancer metastasis: A review, International Journal of Cancer, 72, 1–22 (1997).
5. Andreasen, P.A., Egelund, R., and Petersen, H.H.: The plasminogen activation system in tumor growth, invasion, and metastasis, Cellular and Molecular Life Sciences, 57, 25–40 (2000).
6. Aznavoorian, S., Stracke, M.L., Krutzsch, H., Schiffmann, E., and Liotta, L.A.: Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells, Journal of Cell Biology, 110, 1427–1438 (1990).
7. 3 mediates chemotactic and haptotactic motility in human melanoma cells through different signaling pathways, Journal of Biological Chemistry, 271, 3247–3254 (1996).
8. Bray, D.: Cell Movements from Molecules to Motility, Garland Publishing, New York (2000).
9. Carmeliet, P., and Jain, R.K.: Angiogenesis in cancer and other diseases, Nature, 407, 249–257 (2000)
10. Chang, L., Kaipainen, A., and Folkman, J.: Lymphangiogenesis new mechanisms, Annals New York Academy of Sciences, 979, 111–119 (2002).
11. Chaplain, M.A.J.: Avascular growth, angiogenesis and vascular growth in solid tumours: The mathematical modelling of the stages of tumour development, Mathematical and Computer Modelling, 23, 47–87 (1996).
12. Chaplain, M.A.J.: Mathematical modelling of angiogenesis, Journal of Neuro-Oncology, 50, 37–51 (2000).
13. Chaplain, M.A.J., and Lolas, G.: Mathematical modelling of cancer cell invasion of tissue: The role of the urokinase plasminogen activation system, Mathematical Models and Methods in Applied Sciences, 15 (11), 1685–1734 (2005).
14. Enholm, B., Paavonen, K., Ristimäki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., Eriksson, U., and Alitalo, K.: Comparison of VEGF, VEGF-B, VEGF-C and Ang-1 mRNA regulation by serum, growth factors, oncoproteins and hypoxia, Oncogene, 14, 2475–2483 (1997).
15. Fidler, I.J.: Tumor heterogeneity and the biology of cancer invasion and metastasis, Cancer Research, 38, 2651–2660 (1978).
16. Folkman, J.: Tumor angiogenesis: Therapeutic implications, New England Journal of Medicine, 285, 1182–1186 (1971).
17. Folkman, J.: The vascularization of tumors, Scientific American, 234, 58–73 (1976).
18. Folkman, J.: Tumor angiogenesis, In: Cancer Medicine, Bast, R.C., Kufe, D.W., Pollock, R.E., Weichselbaum, R.R., Holland, J.F., Frei, E., and Gansler, T.S., editors, Decker, Ontario, Canada, 132–152 (2000).
19. Hanahan, D., and Weinberg, R.A.: The hallmarks of cancer, Cell, 100, 57–70 (2000).
20. Hong, Y-H., and Detmar, M.: Prox1, master regulator of the lymphatic vasculature phenotype, Cell & Tissue Research, 314, 85–92 (2003).
21. Jackson, D.G., Prevo, R., Clasper, S., and Banerji, S.: LYVE-1, the lymphatic system and tumor lymphangiogenesis, TRENDS in Immunology, 22, 317–321 (2001).
22. Ji, R-C.: Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics, Cancer Metastasis Reviews, 25, 677–694 (2006).
23. Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., and Alitalo, K.: A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases, The EMBO Journal, 15, 1751 (1996).
24. Joukov, V., Sorsa, T., Kumar, V., Jeltsch, M., Claesson-Welsh, L., Cao, Y., Saksela, O., Kalkkinen, N., and Alitalo, K.: Proteolytic processing regulates receptor specificity and activity of VEGF-C, European Molecular Biology Organization Journal, 16, 3898–3911 (1997).
25. Jussila, L.: Ph.D. Thesis: VEGFR-3 in angiogenesis and lymphangiogenesis, University of Helsinki, Finland (2001).
26. Jussila, L., and Alitalo, K.: Vascular growth factors and lymphangiogenesis, Physiological Reviews, 82, 673–700 (2002).
27. Karkkainen, M.J., Mäkinen, T., and Alitalo, K.: Lymphatic endothelium: a new frontier of metastasis research, Nature Cell Biology, 4, E2–E5 (2002).
28. Karpanen, T., and Alitalo, K.: Lymphatic vessels as targets of tumor therapy, Journal of Experimental Medicine, 194, F37–F42 (2001).
29. Korpelainen, E.I., and Alitalo, K.: Signaling angiogenesis and lymphangiogenesis, Current Opinion in Cell Biology, 10, 159–164 (1998).
30. Levine, H.A., Sleeman, B.D., and Nilsen-Hamilton, M.: A mathematical model for the role of pericytes and macrophages in the initiation of angiogenesis: I. The role of protease inhibitors in preventing angiogenesis, Mathematical Biosciences, 168, 77–115 (2000).
31. Levine, H.A., Pamuk, S., Sleeman, B.D., and Nilsen-Hamilton, M.: Mathematical modeling of capillary formation and development in tumor angiogenesis: penetration into the stroma, Bulletin of Mathematical Biology, 63, 801–863 (2001).
32. Levine, H.A., Sleeman, B.D., and Nilsen-Hamilton, M.: Mathematical modeling of the onset of capillary formation initiating angiogenesis, Journal of Mathematical Biology, 42, 195–238 (2001).
33. Liotta, L.A., Steeg P.S., and Stetler-Stevenson W.G.: Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation, Cell, 64, 327– 336 (1991).
34. Lolas, G.: Ph.D. Thesis: Mathematical modelling of the urokinase plasminogen activation system and its role in cancer invasion of tissue, University of Dundee, Scotland (2003).
35. Lolas, G., Friedman, A.: Lymphangiogenesis in tumors: A mathematical model, submitted for publication, (2007).
36. Mäkinen, T., Veikkola, T., Mustjoki, S., Karpanen, T., Catimel, B., Nice, E.C., Wise, L., Mercer, A., Kowalski, H., Kerjaschki, D., Stacker, S.A., Achen, M.G., and Alitalo, K.: Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3, European Molecular Biology Organization Journal, 20, 4762–4773 (2001).
37. Mandriota, S.J., Jussila, L., Jeltsch M., Compagni, A., Baetens, D., Prevo, R., Banerji, S., Huarte, J., Montesano, R., Jackson, D.G., Orci, L., Alitalo, K., Christofori, G., and Pepper, M.S.: Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis, European Molecular Biology Organization Journal, 20, 672–682 (2001).
38. McCarthy, J.B., Palm, S.L., and Furcht, L.T.: Migration by haptotaxis of a schwann cell tumor line to the basement membrane glycoprotein lamini, Journal of Cell Biology, 97, 772–777 (1983).
39. McCarthy, J.B., and Furcht, L.T.: Laminin and fibronectin promote the haptotactic migration of B16 mouse melanoma cells in vitro, Journal of Cell Biology, 98, 1474–1480 (1984).
40. McCarthy, J.B., Hagen, S.T., and Furcht, L.T.: Human fibronectin contains distinct adhesion- and motility-promoting domains for metastatic melanoma cells, Journal of Cell Biology, 102, 179–188 (1986).
41. McColl, B.K., Baldwin, M.E., Roufail, S., Freeman, C., Moritz, R.L., Simpson, R.J., Alitalo, K., Stacker, S.A., and Achen, M.G.: Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D, The Journal of Experimental Medicine, 198, 863–868 (2003).
42. Nagy, J.A., Vasile, E., Feng, D., Sundberg, C., Brown, L.F., Detmar, M.J., Lawitts, J.A., Benjamin, L., Tan, X., Manseau, E.J., Dvorak, A.M., and Dvorak, H.F.: Vascular permeability factor/vascular endothelial growth factor induces lymphangiogenesis as well as angiogenesis, Journal of Experimental Medicine, 196, 1497–1506 (2002).
43. Oh, C.W., Hoover-Plow, J., and Plow, E.F.: The role of plasminogen in angiogenesis in vivo, Journal of Thrombosis and Haemostasis, 1, 1683–1687 (2003).
44. Oh, S-J., Jeltsch, M.M., Birkenhäger, R., McCarthy, J.E.G., Weich, H.A., Christ, B., Alitalo, K., and Wilting, J.: VEGF and VEGF-C: Specific Induction of angiogenesis and lymphangiogenesis in the differentiated avian chorioallantoic membrane, Developmental Biology, 188, 96–109 (1997).
45. Oliver, G.: Lymphatic vasculature development, Nature Reviews Immunology, 4, 35–45 (2004).
46. Oliver, G., and Detmar, M.: The rediscovery of the lymphatic system: Old and new insights into the development and biological function of the lymphatic vasculature, Genes & Development, 16, 773–783 (2002).
47. Orme, M.E., and Chaplain, M.A.J.: Two-dimensional models of tumour angiogenesis and anti-angiogenesis strategies, IMA Journal of Mathematics Applied in Medicine & Biology, 14, 189–205 (1997).
48. Partanen, T.A., Arola, J., Saaristo, A., Jussila, L., Ora, A., Miettinen, M., Stacker, S.A., Achen, M.G., and Alitalo, K.: VEGF-C and VEGF-D expression in neuroendocrine cells and their receptor, VEGFR-3, in fenestrated blood vessels in human tissues, The FASEB Journal, 14, 2087–2096 (2000).
49. Partanen, T.A., and Paavonen, K.: Lymphatic versus blood vascular endothelial growth factors and receptors in humans, Microscopy Research and Technique, 55, 108–121 (2001).
50. Pepper, M.S.: Lymphangiogenesis and tumor metastasis: Myth or reality?, Clinical Cancer Research, 7, 462–468 (2001).
51. Pepper, M.S., Ferrara, N., Orci, L., and Montesano, R.: Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitors-1 in microvascular endothelial cells, Biochemical and Biophysical Research Communications, 189, 824–831 (1991).
52. Pepper, M.S., Wasi, S., Ferrara, N., Orci, L., and Montesano, R.: In vitro angiogenic and proteolytic properties of bovine lymphatic endothelial cells, Experimental Cell Research, 210, 298–305 (1994).
53. Pepper, M.S., Mandriota, S.J., Jeltsch, M., Kumar, V., and Alitalo, K.: Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity, Journal of Cellular Physiology, 177, 439– 452 (1998).
54. Pepper, M.S., and Skobe, M.: Lymphatic endothelium: Morphological, molecular and functional properties, Journal of Cell Biology, 163, 209–213 (2003).
55. Pepper, M.S., Tille, J-C., Nisato, R., and Skobe, M.: Lymphangiogenesis and tumor metastasis, Cell Tissue Research, 314, 167–177 (2003).
56. Plate, K.H.: From angiogenesis to lymphangiogenesis, Nature Medicine, 7, 151– 152 (2001).
57. Podgrabinska, S., Braun, P., Velasco, P., Kloos, B., Pepper, M.S., Jackson, D.G., and Skobe, M.: Molecular characterization of lymphatic endothelial cells, Proceedings of the National Academy of Sciences, 99, 16069–16074 (2002).
58. Rakic, J.M., Maillard, C., Jost, M., Bajou, K., Masson, V., Devy, L., Lambert, V., Foidart, J.M., and Nöel, A.: Role of plasminogen activator-plasmin system in tumor angiogenesis, Cellular and Molecular Life Sciences, 60, 463–473 (2003).
59. Reis-Filho, J.S., and Schmitt, F.C.: Lymphangiogenesis in tumors: What do we know?, Microscopy Research and Technique, 60, 171–180 (2003).
60. Ristimäki, A., Narko, K., Enholm, B., Joukov, V., and Alitalo, K.: Proinflamma-tory cytokines regulate expression of the lymphatic endothelial mitogen vascular endothelial growth factor-C, The Journal of Biological Chemistry, 8413–8418 (1998).
61. Ruoslahti, E.: How cancer spreads, Scientific American, 275, 72–77 (1996).
62. Schoppmann, S.F., Birner, P., Stöckl, J., Kalt, R., Ullrich, R., Caucig, C., Kriehuber, E., Nagy, K., Alitalo, K., and Kerjaschki, D.: Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis, American Journal of Pathology, 161, 947–956 (2002).
63. Shayan, R., Achen, M.G., and Stacker, S.A.: Lymphatic vessels in cancer metastasis: Bridging the gaps, Carcinogenesis, 27, 1729–1738 (2006).
64. Sidenius, N., and Blasi, F.: The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy, Cancer and Metastasis Reviews, 22, 205–222 (2003).
65. Skobe, M., Hamberg, L.M., Hawighorst, T., Schirner, M., Wolf, G.L., Alitalo, K., and Detmar, M.: Concurrent induction of lymphangiogenesis, angiogenesis, and macrophage recruitment by vascular endothelial growth factor-C in melanoma, Americal Journal of Pathology, 159, 893–903 (2001a).
66. Skobe, M., Hawighorst, T., Jackson, D.G., Prevo, R., Janes, L., Velasco, P., Ric-cardi, L., Alitalo, K., Claffey, K., and Detmar, M.: Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nature Medicine, 7, 192–198 (2001b).
67. Sleeman, J.P.: The lymph node as a bridgehead in the metastatic dissemination of tumors, in: Schlag P.M., Veronesi U. (Eds.), Lymphatic Metastasis and Sentinel Lymphonodectomy, Springer, New York, 55–81 (2000).
68. Stacker, S.A., Stenvers, K., Caesar, C., Vitali, A., Domagala, T., Nice, E., Roufail, S., Simpson, R.J., Moritz, R., Karpanen, T., Alitalo, K., and Achen, M.G.: Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers, Journal of Biological Chemistry, 274, 32127–32136 (1999).
69. Stacker, S.A., Achen, M.G., Jussila, L., Baldwin, M.E., and Alitalo, K.: Lymphangiogenesis and cancer metastasis, Nature Reviews, 2, 573–583 (2002a).
70. Stacker, S.A., Baldwin, M.E., and Achen, M.G.: The role of tumor lymphangiogenesis in metastatic spread, The FASEB Journal, 16, 922–934 (2002b).
71. Swartz, M.A., and Skobe, M.: Lymphatic function, lymphangiogenesis, and cancer metastasis, Microscopy Research and Technique, 55, 92–99 (2001).
72. Taraboletti, G., Roberts, D.D., and Liotta, L.A.: Thrombospondin-induced tumor cell migration: Haptotaxis and chemotaxis are mediated by different molecular domains, Journal of Cell Biology, 105, 2409–2415 (1987).
73. ∆N∆C-and VEGF-A-induced angiogenesis in vitro, Experimental Cell Research, 285, 286–298 (2003).
74. Valtola, R., Salven, P., Heikkilä, P., Taipale, J., Joensuu, H., Rehn, M., Pihla-janiemi, T., Weich, H., deWaal, R., and Alitalo, K.: VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer, American Journal of Pathology, 154, 1381–1390 (1999).